Palvella Therapeutics, Inc (PVLA) — Cash Flow Quality Index
Palvella Therapeutics, Inc (PVLA) has a Cash Flow Quality Index of -0.73x as of December 2023. Operating cash flow of $-13.70 Million is below net income of $18.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Palvella Therapeutics, Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Palvella Therapeutics, Inc Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Palvella Therapeutics, Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Palvella Therapeutics, Inc.
Annual Cash Flow Quality Index for Palvella Therapeutics, Inc (2023–2023)
Year-by-year earnings quality comparison for Palvella Therapeutics, Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.73x | $-13.70 Million | $18.69 Million | — |